Dr. Abdulraheem Yacoub is a professor of medicine at the the University of Kansas, and an internationally recognized expert in Myeloid cancers. he is an active clinical investigator and has contributed to pivotal data that resulted in many FDA approvals.  He was trained in saint louis University and the University of Arkansas for Medical Sciences.